stella
beta
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH) — Stella
Recruiting
Back to Congenital Diaphragmatic Hernia trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Primary Children's Hospital, Salt Lake City, Utah
View full record on ClinicalTrials.gov